These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1932 related items for PubMed ID: 28806116

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Therapy for Stage IV Non-Small-Cell Lung Cancer Without Driver Alterations: ASCO Living Guideline.
    Singh N, Temin S, Baker S, Blanchard E, Brahmer JR, Celano P, Duma N, Ellis PM, Elkins IB, Haddad RY, Hesketh PJ, Jain D, Johnson DH, Leighl NB, Mamdani H, Masters G, Moffitt PR, Phillips T, Riely GJ, Robinson AG, Rosell R, Schiller JH, Schneider BJ, Spigel DR, Jaiyesimi IA.
    J Clin Oncol; 2022 Oct 01; 40(28):3323-3343. PubMed ID: 35816668
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Systemic Therapy for Stage IV Non-Small-Cell Lung Cancer: American Society of Clinical Oncology Clinical Practice Guideline Update.
    Masters GA, Temin S, Azzoli CG, Giaccone G, Baker S, Brahmer JR, Ellis PM, Gajra A, Rackear N, Schiller JH, Smith TJ, Strawn JR, Trent D, Johnson DH, American Society of Clinical Oncology Clinical Practice.
    J Clin Oncol; 2015 Oct 20; 33(30):3488-515. PubMed ID: 26324367
    [Abstract] [Full Text] [Related]

  • 5. Immune Checkpoint Inhibitors for Patients With Advanced Non-Small-Cell Lung Cancer: A Systematic Review.
    Ellis PM, Vella ET, Ung YC.
    Clin Lung Cancer; 2017 Sep 20; 18(5):444-459.e1. PubMed ID: 28416123
    [Abstract] [Full Text] [Related]

  • 6. A Randomized Phase II Study Comparing Nivolumab With Carboplatin-Pemetrexed for Patients With EGFR Mutation-Positive Nonsquamous Non-Small-Cell Lung Cancer Who Acquire Resistance to Tyrosine Kinase Inhibitors Not Due to a Secondary T790M Mutation: Rationale and Protocol Design for the WJOG8515L Study.
    Hayashi H, Chiba Y, Sakai K, Fujita T, Yoshioka H, Sakai D, Kitagawa C, Naito T, Takeda K, Okamoto I, Mitsudomi T, Kawakami Y, Nishio K, Nakamura S, Yamamoto N, Nakagawa K.
    Clin Lung Cancer; 2017 Nov 20; 18(6):719-723. PubMed ID: 28623122
    [Abstract] [Full Text] [Related]

  • 7. Therapy for Stage IV Non-Small-Cell Lung Cancer With Driver Alterations: ASCO and OH (CCO) Joint Guideline Update.
    Hanna NH, Robinson AG, Temin S, Baker S, Brahmer JR, Ellis PM, Gaspar LE, Haddad RY, Hesketh PJ, Jain D, Jaiyesimi I, Johnson DH, Leighl NB, Moffitt PR, Phillips T, Riely GJ, Rosell R, Schiller JH, Schneider BJ, Singh N, Spigel DR, Tashbar J, Masters G.
    J Clin Oncol; 2021 Mar 20; 39(9):1040-1091. PubMed ID: 33591844
    [Abstract] [Full Text] [Related]

  • 8. FDA Approval Summary: Nivolumab for the Treatment of Metastatic Non-Small Cell Lung Cancer With Progression On or After Platinum-Based Chemotherapy.
    Kazandjian D, Suzman DL, Blumenthal G, Mushti S, He K, Libeg M, Keegan P, Pazdur R.
    Oncologist; 2016 May 20; 21(5):634-42. PubMed ID: 26984449
    [Abstract] [Full Text] [Related]

  • 9. Pembrolizumab plus chemotherapy versus chemotherapy alone in patients with advanced non-small cell lung cancer without tumor PD-L1 expression: A pooled analysis of 3 randomized controlled trials.
    Borghaei H, Langer CJ, Paz-Ares L, Rodríguez-Abreu D, Halmos B, Garassino MC, Houghton B, Kurata T, Cheng Y, Lin J, Pietanza MC, Piperdi B, Gadgeel SM.
    Cancer; 2020 Nov 15; 126(22):4867-4877. PubMed ID: 32914866
    [Abstract] [Full Text] [Related]

  • 10. Pointed Progress in Second-Line Advanced Non-Small-Cell Lung Cancer: The Rapidly Evolving Field of Checkpoint Inhibition.
    Melosky B, Chu Q, Juergens R, Leighl N, McLeod D, Hirsh V.
    J Clin Oncol; 2016 May 10; 34(14):1676-88. PubMed ID: 26884577
    [Abstract] [Full Text] [Related]

  • 11. Immune checkpoint inhibitors, alone or in combination with chemotherapy, as first-line treatment for advanced non-small cell lung cancer. A systematic review and network meta-analysis.
    Dafni U, Tsourti Z, Vervita K, Peters S.
    Lung Cancer; 2019 Aug 10; 134():127-140. PubMed ID: 31319971
    [Abstract] [Full Text] [Related]

  • 12. The relationship between blood-based tumor mutation burden level and efficacy of PD-1/PD-L1 inhibitors in advanced non-small cell lung cancer: a systematic review and meta-analysis.
    Ba H, Liu L, Peng Q, Chen J, Zhu YD.
    BMC Cancer; 2021 Nov 13; 21(1):1220. PubMed ID: 34774004
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Comparative analysis of immune checkpoint inhibitors and chemotherapy in the treatment of advanced non-small cell lung cancer: A meta-analysis of randomized controlled trials.
    Khan M, Lin J, Liao G, Tian Y, Liang Y, Li R, Liu M, Yuan Y.
    Medicine (Baltimore); 2018 Aug 13; 97(33):e11936. PubMed ID: 30113497
    [Abstract] [Full Text] [Related]

  • 16. The efficacy and safety of nivolumab, pembrolizumab, and atezolizumab in treatment of advanced non-small cell lung cancer.
    Chen R, Tao Y, Xu X, Shan L, Jiang H, Yin Q, Pei L, Cai F, Ma L, Yu Y.
    Discov Med; 2018 Oct 13; 26(143):155-166. PubMed ID: 30586539
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. First-Line Treatment of Non-Small-Cell Lung Cancer (NSCLC) with Immune Checkpoint Inhibitors.
    Bylicki O, Barazzutti H, Paleiron N, Margery J, Assié JB, Chouaïd C.
    BioDrugs; 2019 Apr 13; 33(2):159-171. PubMed ID: 30825132
    [Abstract] [Full Text] [Related]

  • 19. Toxicity management with combination chemotherapy and programmed death 1/programmed death ligand 1 inhibitor therapy in advanced lung cancer.
    Hoffner B, Leighl NB, Davies M.
    Cancer Treat Rev; 2020 Apr 13; 85():101979. PubMed ID: 32078962
    [Abstract] [Full Text] [Related]

  • 20. Immune Checkpoint Inhibitor Therapy: What Line of Therapy and How to Choose?
    Ramamurthy C, Godwin JL, Borghaei H.
    Curr Treat Options Oncol; 2017 Jun 13; 18(6):33. PubMed ID: 28534248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 97.